CRISPR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1CG?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	374,024	0.438%
General Public	22,531,092	26.4%
Institutions	62,448,363	73.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.5%.

Top Shareholders

Top 25 shareholders own 59.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.7%	ARK Investment Management LLC	9,122,493	CHF 340.1m	21.7%	2.77%
9.79%	Capital Research and Management Company	8,352,553	CHF 311.4m	1%	0.02%
6.95%	Nikko Asset Management Co., Ltd.	5,935,253	CHF 221.3m	88.3%	0.09%
3.51%	State Street Global Advisors, Inc.	2,992,988	CHF 111.6m	25%	no data
3.27%	BlackRock, Inc.	2,795,299	CHF 104.2m	0.63%	no data
3.24%	T. Rowe Price Group, Inc.	2,761,233	CHF 103.0m	-12.4%	0.01%
2.78%	FMR LLC	2,376,011	CHF 88.6m	1.01%	0.01%
2.02%	The Vanguard Group, Inc.	1,725,419	CHF 64.3m	-1.32%	no data
1.86%	New Enterprise Associates, Inc.	1,587,854	CHF 59.2m	0%	3.44%
1.63%	EcoR1 Capital, LLC	1,389,276	CHF 51.8m	0%	2.01%
1.58%	UBS Asset Management AG	1,349,914	CHF 50.3m	20.7%	0.01%
1.23%	SR One Capital Management, LP	1,048,951	CHF 39.1m	0%	9.55%
1.18%	Geode Capital Management, LLC	1,008,214	CHF 37.6m	3.62%	no data
1.11%	Loomis Sayles & Company, L.P.	945,267	CHF 35.2m	-6.06%	0.05%
0.99%	Baker Bros. Advisors LP	843,075	CHF 31.4m	743%	0.34%
0.97%	Dimensional Fund Advisors LP	824,606	CHF 30.7m	-13.2%	0.01%
0.92%	Contrarius Investment Management Ltd.	783,898	CHF 29.2m	14.3%	1.71%
0.85%	Charles Schwab Investment Management, Inc.	724,241	CHF 27.0m	0.92%	no data
0.76%	Norges Bank Investment Management	650,208	CHF 24.2m	0%	no data
0.73%	Balyasny Asset Management L.P.	623,650	CHF 23.3m	588%	0.07%
0.71%	Bellevue Asset Management AG	610,000	CHF 22.7m	-1.24%	0.31%
0.69%	Morgan Stanley, Investment Banking and Brokerage Investments	591,190	CHF 22.0m	9.5%	no data
0.61%	Citadel Advisors LLC	518,547	CHF 19.3m	264%	0.02%
0.59%	Bank of America Corporation, Asset Management Arm	504,388	CHF 18.8m	64.8%	0.01%
0.59%	Merrill Lynch & Co. Inc., Banking Investments	503,464	CHF 18.8m	-9.75%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/04 08:48
End of Day Share Price	2024/10/08 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CRISPR Therapeutics AG is covered by 46 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Huidong Wang	Barclays
Evan Seigerman	BMO Capital Markets Equity Research